SNMMI First-in-Human Radiopharmaceutical Trial Workshop

SEPTEMBER 17, 2026

Virtual Registration Now Open

Help Shape the Future of Early-Phase Radiopharmaceutical Development

As radiopharmaceutical development advances at an unprecedented pace, it brings new opportunities—and new questions—for early-phase clinical research. As radiopharmaceutical trials expand globally, the U.S. has an opportunity to strengthen the pathways that support first-in-human research.

This one-day SNMMI First-in-Human Radiopharmaceutical Trial Workshop brings together leaders from academia, industry, and the regulatory community to explore how first-in-human radiopharmaceutical studies can move forward more efficiently while maintaining the highest standards for patient safety.

Stay Ahead of What’s Next

Keeping pace requires more than awareness. SNMMI's program offers timely context on the CMC, preclinical, and clinical trial design considerations influencing early-stage development—and how those discussions may affect your work long after the event ends.

During this workshop, you'll:

Examine current approaches to Chemistry, Manufacturing, and Controls (CMC), preclinical requirements, and clinical trial design.
Consider how evolving regulatory initiatives could influence future first-in-human studies.
Compare perspectives from academia, industry, and the broader regulatory community.
Follow the conversations driving the future of radiopharmaceutical development in the United States.

Join the Conversation

This workshop is designed for professionals involved in the development of diagnostic and therapeutic radiopharmaceuticals, including:

Pharmaceutical professionals
Clinical researchers
Nuclear medicine physicians
Radiochemists
Radiopharmacists

Show Your Brand’s Commitment to Scientific Advancement

Position your organization alongside the researchers, industry professionals, and regulatory experts helping shape the future of first-in-human radiopharmaceutical research.

Become a Sponsor